For a long time, viruses have been shown to modify the clinical picture of several
autoimmune diseases, including type 1 diabetes (T1D), systemic lupus erythematosus (SLE), …

Antimicrobial resistance is one of the most serious public health issues facing humans since
the discovery of antimicrobial agents. The frequent, prolonged, and uncontrolled use of …

Understanding immune responses to viral infections is crucial to progress in the quest for
effective infection prevention and control. The host immunity involves various mechanisms to …

Background Long-term effectiveness of COVID-19 mRNA boosters in populations with different
previous infection histories and clinical vulnerability profiles is inadequately understood. …

Objectives: Over the last decades, there has been a significant increase in antimicrobial
prescribing and consumption associated with the development of patients' adverse events and …

Background Protection against SARS-CoV-2 symptomatic infection and severe COVID-19 of
previous infection, mRNA two-dose vaccination, mRNA three-dose vaccination, and hybrid …

Background: The ongoing pandemic of SARS-COV-2 has already infected more than eight
million people worldwide. The majority of COVID-19 patients either are asymptomatic or have …

COVID-19 complications still present a huge burden on healthcare systems and warrant
predictive risk models to triage patients and inform early intervention. Here, we profile 893 …

Effectiveness of the 50-μg mRNA-1273.214 bivalent vaccine against SARS-CoV-2 infection
was modest at 25% in a matched, retrospective, cohort study in Qatar comparing infection …

Background Waning of natural infection protection and vaccine protection highlight the need
to evaluate changes in population immunity over time. Population immunity of previous …